Semaglutide – 5mg

Semaglutide, the active ingredient in both Ozempic and Wegovy, is a GLP-1 receptor agonist medication that regulates blood sugar and reduces appetite by mimicking the hormone GLP-1. Originally developed for type 2 diabetes treatment, it's gained popularity for significant weight loss effects. While Ozempic is primarily marketed for diabetes, Wegovy contains the same compound but is specifically dosed for weight management. Administered as a weekly injection, common side effects include nausea, vomiting, and digestive issues.